Manjit Rahelu
Corporate Officer/Principal at ARECOR THERAPEUTICS PLC
Profile
Manjit Rahelu is the founder of Alcheme Advisors.
Currently, he is the Chief Business Officer at Arecor Therapeutics Plc.
Previously, he held positions as Director & Chief Business Officer at Centauri Therapeutics Ltd., Vice President-Business Development at Convergence Pharmaceuticals Ltd., and Chief Operating & Business Officer at Calchan Ltd.
He holds a doctorate from the University of Birmingham and an undergraduate degree from the University of Sussex.
Manjit Rahelu active positions
| Companies | Position | Start |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | 2023-04-04 |
Former positions of Manjit Rahelu
| Companies | Position | End |
|---|---|---|
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
| Alcheme Advisors | Founder | - |
Calchan Ltd.
 Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Chief Operating Officer | - |
Centauri Therapeutics Ltd.
 Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Director/Board Member | - |
Training of Manjit Rahelu
| University of Birmingham | Doctorate Degree |
| University of Sussex | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private companies | 4 |
|---|---|
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
Centauri Therapeutics Ltd.
Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Health Technology |
| Alcheme Advisors |
- Stock Market
- Insiders
- Manjit Rahelu